Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (801-810 of 839) with videos related to

Pageof 84
Sort By:
European Urology|March 24, 2017
Stromal Gene Expression is Predictive for Metastatic Primary Prostate CancerFan Mo, Dong Lin, Mandeep Takhar, et al.
The Journal of Pathology|February 2, 2012
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancerChunxiao Wu, Alexander W Wyatt, Anna V Lapuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2020
Autoantibody Landscape in Patients with Advanced Prostate CancerWilliam S Chen, Winston A Haynes, Rebecca Waitz, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype StudyYen-Yi Lin, Hamideh Sharifi Noghabi, Stanislav Volik, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.
The Journal of Pathology|May 4, 2012
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancerAnna V Lapuk, Chunxiao Wu, Alexander W Wyatt, et al.
Nature Communications|April 14, 2015
Logging cuts the functional importance of invertebrates in tropical rainforestRobert M Ewers, Michael J W Boyle, Rosalind A Gleave, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
Pageof 84

Showing results (801-810 of 839) with videos related to

Sort By:
Pageof 84
European Urology|March 24, 2017
Stromal Gene Expression is Predictive for Metastatic Primary Prostate CancerFan Mo, Dong Lin, Mandeep Takhar, et al.
The Journal of Pathology|February 2, 2012
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancerChunxiao Wu, Alexander W Wyatt, Anna V Lapuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2020
Autoantibody Landscape in Patients with Advanced Prostate CancerWilliam S Chen, Winston A Haynes, Rebecca Waitz, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype StudyYen-Yi Lin, Hamideh Sharifi Noghabi, Stanislav Volik, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.
The Journal of Pathology|May 4, 2012
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancerAnna V Lapuk, Chunxiao Wu, Alexander W Wyatt, et al.
Nature Communications|April 14, 2015
Logging cuts the functional importance of invertebrates in tropical rainforestRobert M Ewers, Michael J W Boyle, Rosalind A Gleave, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
Pageof 84